BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25139218)

  • 1. Maternal serum PAPP-A as an early marker of obstetric complications?
    Quattrocchi T; Baviera G; Pochiero T; Basile F; Rizzo L; Santamaria A; Corrado F; D'Anna R
    Fetal Diagn Ther; 2015; 37(1):33-6. PubMed ID: 25139218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
    Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
    BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Diabetes, Large-for-Gestational-Age Births, and First Trimester Pregnancy-Associated Plasma Protein-A.
    Wells G; Bleicher K; Han X; McShane M; Chan YF; Bartlett A; White C; Lau SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2372-9. PubMed ID: 25825946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications.
    D'Antonio F; Rijo C; Thilaganathan B; Akolekar R; Khalil A; Papageourgiou A; Bhide A
    Prenat Diagn; 2013 Sep; 33(9):839-47. PubMed ID: 23613261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes.
    Spencer CA; Allen VM; Flowerdew G; Dooley K; Dodds L
    Prenat Diagn; 2008 Nov; 28(11):1029-36. PubMed ID: 18925584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.
    Poon LC; Maiz N; Valencia C; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):23-33. PubMed ID: 19090499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.
    Luewan S; Teja-Intr M; Sirichotiyakul S; Tongsong T
    Singapore Med J; 2018 Jan; 59(1):55-59. PubMed ID: 28451695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester maternal serum pregnancy-specific beta-1-glycoprotein (SP1) as a marker of adverse pregnancy outcome.
    Pihl K; Larsen T; Laursen I; Krebs L; Christiansen M
    Prenat Diagn; 2009 Dec; 29(13):1256-61. PubMed ID: 19911417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased time-to-pregnancy and first trimester Down's syndrome screening.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Hum Reprod; 2010 Feb; 25(2):412-7. PubMed ID: 19945962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of combined serum biomarkers for adverse pregnancy outcomes.
    Cohen JL; Smilen KE; Bianco AT; Moshier EL; Ferrara LA; Stone JL
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():89-94. PubMed ID: 25129153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequent gestational diabetes.
    Beneventi F; Simonetta M; Lovati E; Albonico G; Tinelli C; Locatelli E; Spinillo A
    Prenat Diagn; 2011 Jun; 31(6):523-8. PubMed ID: 21404306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels.
    Scott F; Coates A; McLennan A
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):258-62. PubMed ID: 19566556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and clinical consequences of extremely high maternal serum PAPP-A levels.
    Cuckle H; Arbuzova S; Spencer K; Crossley J; Barkai G; Krantz D; Muller F; Nikolenko M; Aitken D; Hallahan T; Macri J; Buchanan PD
    Prenat Diagn; 2003 May; 23(5):385-8. PubMed ID: 12749035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.
    Yaron Y; Heifetz S; Ochshorn Y; Lehavi O; Orr-Urtreger A
    Prenat Diagn; 2002 Sep; 22(9):778-82. PubMed ID: 12224070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring.
    Fruscalzo A; Cividino A; Rossetti E; Maurigh A; Londero AP; Driul L
    Sci Rep; 2020 Mar; 10(1):5131. PubMed ID: 32198414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Pregnancy-Associated Plasma Protein-A for Predicting Adverse Pregnancy Outcome.
    Mohamad Jafari R; Masihi S; Barati M; Maraghi E; Sheibani S; Sheikhvatan M
    Arch Iran Med; 2019 Oct; 22(10):584-587. PubMed ID: 31679360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
    Poon LC; Nekrasova E; Anastassopoulos P; Livanos P; Nicolaides KH
    Prenat Diagn; 2009 Jun; 29(6):553-9. PubMed ID: 19242924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.